Pacific Biosciences of California Inc (NAS:PACB)
$ 1.645 -0.025 (-1.5%) Market Cap: 448.02 Mil Enterprise Value: 817.48 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 58/100

Pacific Biosciences of California Inc Signs Definitive Agreement to Acquire Omniome Inc Call Transcript

Jul 20, 2021 / 12:30PM GMT
Release Date Price: $29.2 (+7.23%)
Operator

Hello, ladies and gentlemen, and welcome to the Pacific Biosciences to acquire Omniome conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to hand the conference over to your host, Mr. Todd Friedman. Please go ahead.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

Thank you. Good morning, everyone, and thanks for joining us on such short notice to discuss the definitive agreement to acquire -- for Pacific Biosciences to acquire Omniome. If you've not had a chance to read today's release, it can be found in the Investor Relations section at our website at pacb.com.

Participating for PacBio today will be Christian Henry, President and Chief Executive Officer; Susan Kim, Chief Financial Officer; Mark Van Oene, Chief Operating Officer. We're also pleased to welcome Richard Shen, President of Omniome. Christian, Susan and Richard will share some prepared remarks, and then we will open up the call for some questions. The call is being recorded, and the audio portion will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot